ATE228514T1 - Indolin-derivate verwendbar als 5-ht-2c rezeptor- antagonisten - Google Patents

Indolin-derivate verwendbar als 5-ht-2c rezeptor- antagonisten

Info

Publication number
ATE228514T1
ATE228514T1 AT97928224T AT97928224T ATE228514T1 AT E228514 T1 ATE228514 T1 AT E228514T1 AT 97928224 T AT97928224 T AT 97928224T AT 97928224 T AT97928224 T AT 97928224T AT E228514 T1 ATE228514 T1 AT E228514T1
Authority
AT
Austria
Prior art keywords
receptor antagonists
indoline derivatives
derivatives usable
usable
indoline
Prior art date
Application number
AT97928224T
Other languages
English (en)
Inventor
Steven Mark Smithklin Bromidge
Science Park South Frontiers
Ian Thomson Smithkline Forbes
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE228514T1 publication Critical patent/ATE228514T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT97928224T 1996-06-20 1997-06-16 Indolin-derivate verwendbar als 5-ht-2c rezeptor- antagonisten ATE228514T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9612883.0A GB9612883D0 (en) 1996-06-20 1996-06-20 Novel compounds
PCT/EP1997/003156 WO1997048699A1 (en) 1996-06-20 1997-06-16 Indoline derivatives useful as 5-ht-2c receptor antagonists

Publications (1)

Publication Number Publication Date
ATE228514T1 true ATE228514T1 (de) 2002-12-15

Family

ID=10795575

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97928224T ATE228514T1 (de) 1996-06-20 1997-06-16 Indolin-derivate verwendbar als 5-ht-2c rezeptor- antagonisten

Country Status (33)

Country Link
US (1) US6369060B1 (de)
EP (1) EP0912554B1 (de)
JP (1) JP2000512306A (de)
KR (1) KR20000022045A (de)
CN (1) CN1229408A (de)
AP (2) AP9801410A0 (de)
AR (1) AR008243A1 (de)
AT (1) ATE228514T1 (de)
AU (1) AU718597B2 (de)
BG (1) BG103089A (de)
BR (1) BR9709911A (de)
CA (1) CA2258240A1 (de)
CO (1) CO4890847A1 (de)
CZ (1) CZ420598A3 (de)
DE (1) DE69717449T2 (de)
DZ (1) DZ2250A1 (de)
EA (1) EA001780B1 (de)
ES (1) ES2187783T3 (de)
GB (1) GB9612883D0 (de)
HU (1) HUP9903439A3 (de)
ID (1) ID19433A (de)
IL (1) IL127417A0 (de)
MA (1) MA24214A1 (de)
NO (1) NO985972D0 (de)
NZ (1) NZ333229A (de)
OA (1) OA10944A (de)
PE (1) PE86698A1 (de)
PL (1) PL330796A1 (de)
SK (1) SK282706B6 (de)
TR (1) TR199802661T2 (de)
TW (1) TW382015B (de)
WO (1) WO1997048699A1 (de)
ZA (1) ZA975415B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3030899A (en) * 1998-02-25 1999-09-15 Smithkline Beecham Plc Process(es) for the preparation of 6-trifluoromethyl-indoline derivatives
GB0019950D0 (en) * 2000-08-12 2000-09-27 Smithkline Beecham Plc Compounds
JP2005535560A (ja) * 2001-11-28 2005-11-24 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 治療用の化合物
WO2003076426A2 (en) * 2002-03-04 2003-09-18 Pharmacia & Upjohn Company Pyridinyloxy derivatives as 5-ht receptor ligands
KR101062376B1 (ko) * 2008-04-10 2011-09-06 한국화학연구원 신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
CN102348798A (zh) 2009-01-16 2012-02-08 麻省理工学院 孤独症谱系障碍的诊断和治疗
EP2651403B1 (de) 2010-12-17 2020-12-02 Glaxo Group Limited Verwendung von lp-pla2-inhibitoren zur behandlung und vorbeugung von augenerkrankungen
WO2014046544A1 (en) 2012-09-21 2014-03-27 Aapa B.V. Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001333A1 (en) 1987-08-07 1989-02-23 The Australian National University IMIDAZO[1,2-b]PYRIDAZINES
CA2142721A1 (en) 1992-08-20 1994-03-03 Ian T. Forbes Condensed indole derivatives as 5ht and 5ht antagonists
GB9313913D0 (en) * 1993-07-06 1993-08-18 Smithkline Beecham Plc Novel compounds
EA000304B1 (ru) * 1995-02-02 1999-04-29 Смитклайн Бичам Плс Производные индола как антагонисты рецептора 5-ht
GB9607219D0 (en) * 1996-04-04 1996-06-12 Smithkline Beecham Plc Novel compounds
GB9615767D0 (en) * 1996-07-26 1996-09-04 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
AP9701037A0 (en) 1997-07-31
WO1997048699A1 (en) 1997-12-24
SK175298A3 (en) 1999-05-07
CA2258240A1 (en) 1997-12-24
HUP9903439A2 (en) 2000-07-28
GB9612883D0 (en) 1996-08-21
TW382015B (en) 2000-02-11
ZA975415B (en) 1998-12-21
NO985972L (no) 1998-12-18
IL127417A0 (en) 1999-10-28
EA001780B1 (ru) 2001-08-27
CZ420598A3 (cs) 1999-06-16
AP9801410A0 (en) 1998-12-31
CO4890847A1 (es) 2000-02-28
US6369060B1 (en) 2002-04-09
OA10944A (en) 2003-02-27
AP745A (en) 1999-04-28
AU3260297A (en) 1998-01-07
PL330796A1 (en) 1999-06-07
TR199802661T2 (xx) 1999-03-22
ES2187783T3 (es) 2003-06-16
HUP9903439A3 (en) 2002-12-28
AR008243A1 (es) 1999-12-29
DE69717449D1 (de) 2003-01-09
EA199900043A1 (ru) 1999-06-24
SK282706B6 (sk) 2002-11-06
BG103089A (en) 1999-09-30
EP0912554A1 (de) 1999-05-06
PE86698A1 (es) 1999-01-28
ID19433A (id) 1998-07-09
EP0912554B1 (de) 2002-11-27
MA24214A1 (fr) 1997-12-31
DZ2250A1 (fr) 2002-12-18
KR20000022045A (ko) 2000-04-25
NO985972D0 (no) 1998-12-18
AU718597B2 (en) 2000-04-20
BR9709911A (pt) 1999-08-10
NZ333229A (de) 2000-01-28
DE69717449T2 (de) 2003-10-02
CN1229408A (zh) 1999-09-22
JP2000512306A (ja) 2000-09-19

Similar Documents

Publication Publication Date Title
ATE263151T1 (de) Indolderivate verwendbar als endothelinrezeptorantagonisten
ATE197300T1 (de) Indolderivate als 5-ht rezeptorantagoniste
DE69734833D1 (de) Vitronektin rezeptor antagonisten
DE69325167D1 (de) Kondensierte indol-derivate als 5-ht4-rezeptor-antagonisten
ID24726A (id) Antagonis-antagonis reseptor trombin
ID24162A (id) Antagonis-antagonis reseptor vitronektin
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
BR9707733A (pt) Antagonistas de receptores muscarinicos oxa-e-tia-diazol
ATE196766T1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor- antagonisten
ATE228514T1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor- antagonisten
DE69617010T2 (de) Isazole derivate als fibrinogen-rezeptor-antagonisten
ATE206421T1 (de) Heterocyclisch substituierte piperazonderivate als tachykinin rezeptor antagonisten
FI963463A (fi) Indolijohdannaiset CCK-reseptoriantagonisteina
SI0912556T1 (en) Indoline derivatives useful as 5-ht-2c receptor antagonists

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties